Deep Tech Startups

Plasana Medical develops a cold plasma-based medical device for wound healing that accelerates healing time and reduces infection risk. The company targets healthcare providers and patients in France and Europe, with plans to market the device following CE certification.

1 investor

Plaskimia develops a plasma-activated continuous flow chemistry platform that combines plasma chemistry, flow chemistry, and AI to produce fine chemicals, pharmaceutical intermediates, and bio-based derivatives. The platform enables safer, greener synthesis at ambient conditions with 40-80% lower CO₂ emissions for high-value chemical manufacturing.

1 investor

Plasma Processes operates manufacturing facilities specializing in advanced materials processing and additive manufacturing technologies, serving aerospace and defense customers with capabilities including molten salt electrodeposition, plasma spray systems, and laser-based manufacturing.

1 investor

Plasmacure develops cold plasma medical technologies for healthcare, working with researchers, clinicians and industry partners to meet medical and regulatory standards. Its main application is advanced wound care through a device that combines cold plasma with mild electrostimulation.

1 investor

Plasmidsaurus provides fast DNA and RNA sequencing services for scientists, including whole plasmid, whole genome, amplicon, microbiome, RNA-Seq, and AAV sequencing, with bioinformatics tools and annotated data delivered overnight. It serves academic researchers, pharma companies, and life-science labs, offering sample submission via a global network of dropboxes.

1 investor

Pleioflow develops minimally invasive flow assist devices designed to prevent renal failure in cardiac surgery patients and those experiencing acute kidney injury. The company focuses on medical devices for cardiac assist and renal protection applications.

1 investor

Plexistor provides high-speed storage solutions for big data infrastructure that optimize database performance across Apache Cassandra, MongoDB, and MySQL. The company's technology reduces infrastructure costs and latency by replacing expensive memory with near-memory-speed persistent storage.

1 investor

Plexus develops high-performance gloves for virtual reality and augmented reality applications. The company produces hardware for VR and AR users.

1 investor

Plexus Aero provides a software data stack and monitoring platform designed for hardware fleets and physical systems. The platform enables teams managing drones, devices, and hardware-based systems to deploy, monitor, and debug their hardware similar to how software teams manage code deployments.

1 investor

PLT develops human tissue organoids produced in microgravity conditions for use in pharmaceutical testing, precision medicine, and transplantation research. The company manufactures these 3D tissue cultures from stem cells and is developing hardware for commercial-scale organoid production in space.

1 investor

PLU Ophthalmic develops a minimally invasive, implant-free glaucoma surgery technology using precise micro-excision for treating open-angle glaucoma. The company targets ophthalmic surgical care, aiming to improve efficacy, safety, and operating-room throughput for glaucoma patients.

1 investor

Plurify develops manufacturing technology for advanced therapies, specifically cell and gene therapy production. The company's platform addresses scalability, safety, and cost challenges in bioreactor-scale therapeutic manufacturing.

1 investor

Pluvia Biotech is a University of Bergen spin-out developing small molecule pharmacological chaperones that stabilize and correct misfolded proteins to rescue enzymatic activity in rare genetic loss-of-function disorders. Its lead program, PBAS499, targets phenylketonuria (PKU), an inborn metabolic disorder, with plans to apply its drug discovery platform to other protein-misfolding diseases.

1 investor

PNO provides cybersecurity, AI-driven solutions, and high-performance computing for organizations in aerospace, edge computing, public safety, and critical infrastructure. It works as a strategic partner to design tailor-made solutions that protect against threats and use data and intelligence to improve operations.

1 investor

Pointcloud develops a silicon-based 4D imaging sensor platform using Silicon Photonics to provide high-performance 3D perception for machines. Its technology targets applications such as humanoid robots, drones, and autonomous mobility systems in the Physical AI space.

1 investor

Poke & Wiggle works on the data and go-to-market challenges of robot foundation models. The company operates in robotics and AI.

1 investor

Polarean is a medical imaging company that manufactures xenon-based imaging products for healthcare applications and maintains compliance with pharmaceutical industry standards and regulations.

1 investor

Polaris Raumflugzeuge develops Aurora, a reusable spaceplane that combines aircraft and rocket technologies to deliver payloads to orbit and suborbital altitudes from conventional runways. The system is designed for small satellite launch, hypersonic transport, defense applications, and research missions with rapid turnaround and high reusability.

1 investor

POLARIS develops reusable spaceplanes designed to launch from airports and land horizontally, combined with a two-stage launch vehicle called AURORA for small and medium satellites. The company specializes in hypersonic flight technology and rocket engines for orbital and hypersonic missions.

1 investor

Polaris Wireless develops software-based 3D wireless location technology that determines the real-time position of mobile devices. It offers location solutions and integrable products for industries seeking mobile positioning capabilities.

1 investor

Polar Performance Materials supplies ultra-high purity alumina materials to customers in semiconductors, aerospace, sapphire, and other precision industries, with engineered processes designed to minimize contamination and alpha particle emission while reducing energy use.

1 investor

POLASTECH is a deep-tech company developing zeolite-based water-vapor adsorbent materials (AQSOA) and adsorption heat pumps (AHP) that convert low-temperature waste heat from data centers and industrial facilities into cooling energy, reducing electricity use and CO₂ emissions. Carved out from Mitsubishi Chemical, it manufactures and sells AQSOA adsorbents and AHP systems for cooling applications, primarily serving data center and industrial markets in Japan.

1 investor

HUBER+SUHNER Polatis develops optical circuit switches for fiber-layer automation, offering configurations from 8x8 to 384x384 ports. Its POLATIS switches are used for test lab automation, network monitoring, photonic fabrics in AI data centers, and photonic cross connects for quantum applications.

1 investor

Polku Therapeutics is a preclinical CNS drug discovery company developing small-molecule therapies that modulate the PREP–PP2A axis to target tau aggregation and neuroinflammation in neurodegenerative diseases. Its lead program pursues disease-modifying treatments for tauopathies and related conditions such as Parkinson's disease, starting with orphan tauopathy indications.

1 investor